J
James D. Neaton
Researcher at University of Minnesota
Publications - 352
Citations - 68183
James D. Neaton is an academic researcher from University of Minnesota. The author has contributed to research in topics: Risk factor & Blood pressure. The author has an hindex of 101, co-authored 331 publications receiving 64719 citations. Previous affiliations of James D. Neaton include University of Pittsburgh & Medical Research Council.
Papers
More filters
Journal ArticleDOI
Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a south african cohort with advanced HIV disease
Lotty Ledwaba,Jorge A. Tavel,Paul Khabo,Patrick Maja,Jing Qin,Phumele Sangweni,Xiao Liu,Dean Follmann,Julia A. Metcalf,Susan Orsega,Beth Baseler,James D. Neaton,H. Clifford Lane +12 more
TL;DR: Elevated pre-ART levels of hsCRP, IL-6 and D-dimer are strongly associated with early mortality after commencing ART, and these associations were stronger for deaths that occurred more proximal to the biomarker measurements.
Journal ArticleDOI
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.
Richard T. Davey,Eduardo Fernández-Cruz,Norman Markowitz,Sarah Pett,Abdel Babiker,Deborah Wentworth,Surender Khurana,Nicole Engen,Fred M. Gordin,Mamta K. Jain,Virginia L. Kan,Mark N. Polizzotto,Paul F. Riska,Kiat Ruxrungtham,Zelalem Temesgen,Jens D Lundgren,John H. Beigel,H. Clifford Lane,James D. Neaton,Jessica Butts,Eileen Denning,Alain DuChene,Eric A. Krum,Merrie Harrison,Sue Meger,Ross L. Peterson,Kien Quan,Megan Shaughnessy,Greg Thompson,David M. Vock,Julia A. Metcalf,Robin Dewar,Tauseef Rehman,Ven Natarajan,Rose McConnell,Emily Flowers,Kenny Smith,Marie Hoover,Elizabeth M Coyle,David Munroe,Bitten Aagaard,Mary Pearson,Adam Cursley,Helen Webb,Fleur Hudson,Charlotte Russell,Aminata Sy,Cara Purvis,Brooke Jackson,Yolanda Collaco-Moraes,Dianne Carey,Rosemary Robson,Adriana Sánchez,Elizabeth Finley,Donna Conwell,Marcelo H. Losso,Luciana Gambardella,Cecilia Abela,Paco Lopez,Helena Alonso,Giota Touloumi,Vicky Gioukari,Olga Anagnostou,Anchalee Avihingsanon,Kanitta Pussadee,Sasiwimol Ubolyam,Bola Omotosho,Clemencia Solórzano,Tianna Petersen,Kranthi Vysyaraju,Stacey A Rizza,Jennifer A Whitaker,Raquel Nahra,John D. Baxter,Patricia Coburn,Edward M. Gardner,James A Scott,Leslie Faber,Erica Pastor,Linda Makohon,Rodger A MacArthur,L Monique Hillman,Marti J Farrough,Hari M Polenakovik,Linda A Clark,Roberto J Colon,Ken M. Kunisaki,Miranda DeConcini,Susan A Johnson,Cameron R. Wolfe,Laura Mkumba,June Y Carbonneau,Alison Morris,Meghan Fitzpatrick,Cathy J Kessinger,Robert A. Salata,Karen A Arters,Catherine M Tasi,Ralph J. Panos,Laura A Lach,Marshall J. Glesby,Kirsis Ham,Valery G Hughes,Robert T. Schooley,Daniel Crouch,Leticia Muttera,Richard M. Novak,Susan C Bleasdale,Ariel E Zuckerman,Weerawat Manosuthi,Supeda Thaonyen,Thaniya Chiewcharn,Gompol Suwanpimolkul,Sivaporn Gatechumpol,Sirikunya Bunpasang,Brian Angus,Monique Anderson,Marcus Morgan,Jane Minton,Maria N Gkamaletsou,Joe Hambleton,David Price,Martin J Llewelyn,Jonathan Sweetman,Javier Carbone,Jose R. Arribas,Rocio Montejano,Jose L Lobo Beristain,Iñaki Z Martinez,Jose Barberan,Paola Hernandez,Dominic E. Dwyer,Jen Kok,Álvaro H. Borges,Christian Brandt,Lene S Knudsen,Nikolaos Sypsas,Costas S. Constantinou,Antonios Markogiannakis,Spyros Zakynthinos,Paraskevi Katsaounou,Ioannis Kalomenidis,Analia Mykietiuk,Maria F Alzogaray,Mora Obed,Laura Moreno Macias,Juan Ebensrtejin,Patricia Burgoa,Esteban C. Nannini,Matias Lahitte,Santiago Perez-Patrigeon,José Arturo Martínez-Orozco,Juan Pablo Ramírez-Hinojosa +152 more
TL;DR: In this article, the authors evaluated the safety and efficacy of intravenous immunoglobulin (HIVIG) in a randomized controlled trial. But, they did not evaluate the effect of the infusion of high-titre hIVIG on clinical outcomes.
Journal ArticleDOI
Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.
Bertram Pitt,Philip A. Poole-Wilson,Robert Segal,Felipe Martinez,Kenneth Dickstein,A. John Camm,Marvin A. Konstam,Günter A.J. Riegger,George Klinger,James D. Neaton,Divakar Sharma,Balasamy Thiyagarajan +11 more
TL;DR: The ELITE II study will further define the role of losartan in the treatment of patients with symptomatic heart failure relative to the angiotensin-converting enzyme inhibitor captopril, an agent from a class currently considered standard treatment for this disease.
Journal ArticleDOI
Prevalence and prognostic significance of hypercholesterolemia in men with hypertension: Prospective data on the primary screenees of the multiple risk factor intervention trial
Jeremiah Stamler,Jeremiah Stamler,Deborah Wentworth,Deborah Wentworth,James D. Neaton,James D. Neaton +5 more
TL;DR: Serum cholesterol related to coronary heart disease risk in a strong, graded way, over the entire distribution of serum cholesterol, from levels of 182 mg/dl and higher was the case for hypertensive male smokers and nonsmokers.
Journal ArticleDOI
A Longitudinal Study of Ebola Sequelae in Liberia.
Sneller Mc,Cavan S. Reilly,Moses Badio,Rachel Bishop,Allen O. Eghrari,Moses Sj,Kumblytee Johnson,Gayedyu-Dennis D,Lisa E. Hensley,Elizabeth S. Higgs,Avindra Nath,Kaylie Tuznik,Varughese J,Kenneth S. Jensen,Bonnie Dighero-Kemp,James D. Neaton,H C Lane,Mosoka Fallah +17 more
TL;DR: A relatively high burden of symptoms was seen in all participants, but certain symptoms and examination findings were more common among survivors, with the exception of uveitis, which declined in prevalence during follow‐up in both groups.